share_log

3: Initial statement of beneficial ownership of securities-Director McMullen Michael R.

SEC ·  Jul 3 05:35
Summary by Futu AI
Michael R. McMullen, a director and 10% owner of Bristol-Myers Squibb, filed an Initial Statement of Beneficial Ownership of Securities with the SEC on July 1, 2024. The Form 3 submission, which is a requirement under Section 16(a) of the Securities Exchange Act of 1934, indicates that McMullen does not beneficially own any non-derivative or derivative securities of the company. The filing, signed by attorney-in-fact Lisa A. Atkins on behalf of McMullen, was completed on July 2, 2024. This formality is part of the regulatory requirements for individuals in McMullen's position, providing transparency about the holdings of company insiders.
Michael R. McMullen, a director and 10% owner of Bristol-Myers Squibb, filed an Initial Statement of Beneficial Ownership of Securities with the SEC on July 1, 2024. The Form 3 submission, which is a requirement under Section 16(a) of the Securities Exchange Act of 1934, indicates that McMullen does not beneficially own any non-derivative or derivative securities of the company. The filing, signed by attorney-in-fact Lisa A. Atkins on behalf of McMullen, was completed on July 2, 2024. This formality is part of the regulatory requirements for individuals in McMullen's position, providing transparency about the holdings of company insiders.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.